Since the discovery of hepatitis B antigen (Australia antigen) in 1965 leading to the identification of the causative agent of hepatitis B (Blumberg et al., 1965; Prince, 1968; Krugman and Giles, 1970) , awareness of its position as a major source of both acute and chronic disease has been growing (Ohbayashi et al., in Taiwan (Shih et al., 1971; Gerety et al., 1974; Helske, 1976; Chen and Sung, 1977) . Modes of spread of the virus include direct or accidental inoculation of infected blood or blood products through transfusion, intravenous drug abuse, tattooing, acupuncture, dental work, shared razors, laboratory accidents, and perhaps insect vectors (Metselaar et al., 1973; Patterson et al., 1974) , sexual contact (Heathcote et al., 1974b) , and 'vertical' transmission from mother to baby (Turner et al., 1971; Merrill et al., 1972; Papaevangelou et al., 1974; Anderson et al., 1975; Stevens et al., 1975) , probably through ingestion or passage of blood through broken skin or mucous membranes during delivery. Most body fluids, including saliva (Bancroft et al., 1977) , sweat (Telatar et al., 1974) , semen (Heathcote et al., 1974a) , pleural fluid (DeFlora and Forci, 1977) , breast milk (Krugman, 1975) , and blood may contain the virus. Horizontal spread in ways other than through blood seems likely but has not been well defined (Szmuness et al., 1975) .
As the virus is able to persist in man for long periods (after acute hepatitis or without detectable illness), producing so-called 'carriers', defined as those in whom HBsAg is present for more than 6 months (World Health Organisation, 1977) , it would appear that a large reservoir may preclude its eventual eradication.
Through screening and the gradual elimination of HBsAg-positive carriers from panels of blood donors, once an important source of hepatitis, vertical transmission may rapidly become the principal means of viral spread, especially in countries with a large number of carriers. One report (Derso et al., 670 Vertical transmission of hepatitus B surface antigen in carrier mothers in two west London hospitals 671 1978) indicated that certain ethnic groups, particularly the Chinese, may be genetically prone to such transmission, and the increased risk does not appear to be related to the birthplace of the mother but to her ethnic origin. We report here a study based on all the infants delivered of HBsAg-positive carrier mothers at two hospitals in west London, the Hammersmith Hospital and Queen Charlotte's Maternity Hospital. This study appears to confirm earlier work. Some of the mothers from the Hammersmith Hospital were the subject of a previous report The HBeAg status of the 93 mothers tested for this is given in Table 2 . Chinese mothers are much more likely than nonChinese mothers to be HBeAg positive (P<0 001). Eight of the 10 HBeAg-positive mothers produced 9 of the 14 14BsAg-positive children. Of the remaining 2 HBeAg-positive mothers, one was Japanese and had 3 children, all HBsAg negative. We were unable to follow up the child of the other mother.
Children. Of the 126 children 53 (43 %) were girls. We were able to see 110 after the first week of life. The mean age of follow-up was 24-8 months (range 2 months to 5 years 9 months). Three of the remaining 16 had died (one due to congenital heart disease at age one week, and 2 due to cot deaths at ages 3 and 16 months), and 12 could not be located or had parents who refused to allow blood to be taken. From one child, in Malaysia, a blood sample could not be obtained in spite of several attempts.
The results of cord blood testing are given in Table 3. 14 (13%) of the 110 children were later HBsAgpositive, 4 by RIA testing only. Details are given in Table 4 . Five of the 14 were girls. All the children were growing and developing normally, and no hepatomegaly was found. Alanine transaminase (ALT) results were normal in the 9 positive children who were tested. Two of the 14 positive children had received 1 ml of HBIG at birth only; the rest received none. Table 4 shows that 8 of the 13 mothers were positive for HBeAg, and in fact 7 of these 8 were Chinese. In 2 of these Chinese families, both with HBeAg-positive mothers, we were able to test siblings; in one, the sibling was found to be positive, while in the other, she was negative. Six of the 13 fathers were tested and all were HBsAg negative. As noted in Table 4 , one of the children (Case 1) was negative when tested at ages 3, 6, and 12 months, but at ages 15 and 24 months she was RIA positive. This may indicate some form of horizontal transmission. Her father was negative for HBsAg.
There was no significant difference in the incidence of breast feeding between the groups of positive and negative children.
Discussion
Our results reflect the mixed ethnic origins of the population in London and seem to confirm the findings of others regarding a racial tendency to vertical transmission of the HBV, as detected by the presence of HBsAg. There have been interesting theories regarding the genetics of such transmission (Hug, 1976; Blumberg, 1977) .
Some recent work has dealt with the sex distribution of carriers, as more men than women are carriers (Goodman et al., 1971; Curtis et al., 1973) , and it also seems that where one parent is a positive HBsAg carrier, there is an increased secondary sex ratio (number of males per 100 females) (Drew et al., 1978) . Our 102 mothers have produced, to our knowledge, a total of 223 children, 125 (56%) boys and 98 (44%) girls. The numbers are too small for valid analysis, however, and complete data are not available.
Our cord blood results, as those of others (Aziz et al., 1973) , would appear to show the unreliability of such specimens in predicting the future HBsAg status of the child. Contamination with maternal blood may account for most if not all positive cord bloods; in several cases in which cord blood was positive, a blood sample from the infant was checked and found to be negative. In fact, at Hammersmith Hospital cord blood testing is no longer done; instead a specimen is taken from the child some time during its first week of life. In utero transmission has been reported but is thought to be rare (Schweitzer and Spears, 1970) , and usually comes not from carrier mothers but from overt cases of hepatitis during the last trimester of pregnancy or early in the postpartum period (Schweitzer et al., 1972 (Schweitzer et al., , 1973 .
The HBeAg positive state of the mother increased the transmission of HBV to the child, as has been shown by others (Beasley et al., 1977; Chaudhuri et al., 1977; Gerety and Schweitzer, 1977; Murata et al., 1977) . Anti-HBe was not necessarily protective, as can be seen from Table 2 , although this has been suggested (Okada et al., 1976) . There are those who now say that HBeAg may not be a marker of HBV but an indication of liver damage (Fay et al., 1977; Tiku et al., 1977; Vyas et al., 1977 (Dosik and Jhaveri, 1978; Twarson and Norkrans, 1978) . It is concluded that an adequate trial of HBIG prophylaxis is not feasible in London or elsewhere in the UK, where there are so few carrier mothers.
Concerning the continued surveillance of the children with HBsAg-positive mothers, we would agree with those (Melnick et al., 1976; Woolf and Williams, 1976; Barker et al., 1978) who feel blood should be tested at birth, 6 months, and 12 months, and if the child remains negative, he could be discharged (although we did have one conversion after this age). In the case of children found to be positive, yearly examinations and liver function tests for life ought to be considered. This would not necessarily be adequate in diagnosing chronic active hepatitis or hepatocellular carcinoma, but at least one's index of suspicion would be high. It would seem that very long-term follow-up studies will be needed before questions such as the necessity for frequent liver biopsies can be answered adequately. Management of the carrier has been discussed at length (Cossart, 1977) .
Mothers, too, ought to be referred for follow-up in medical clinics once their obstetric need has ended (Babb, 1976) . We found that few of the women were seen regularly except for antenatal care. We tended to be reassuring about good future health, despite the mounting evidence of possible liver disease later, as almost all our mothers were very upset at the idea of being 'infectious' and a few felt constrained in handling their new babies.
Mothers were warned about the need for care in handling their own blood from any source, as well as the need to inform their dentists and anyone who might later seek blood samples (general practitioners were officially informed). When a child was found to be positive we gave similar advice, but have found that perhaps the child's positive status should not be mentioned at school, as he may then be regarded with suspicion. One 6-month-old child in our study was rejected by a nursery as a result of this information, probably due to fear and ignorance by the nursery staff. There have been studies in schools indicating that crossinfection in groups of schoolchildren does not occur (Follett et al., 1978) .
Micromethods are being developed for HBV screening using finger prick blood samples on filter paper (Farzadegan et al., 1978) . Perhaps with the perfection of such methods, very large population studies may become feasible. 
